Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients-Reference-Cited by-同舟云学术

Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients

Published:2023-10 Issue:10 Volume:4 Page:101241
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Rotolo Antonia,Whelan Eoin C.,Atherton Matthew J.^ORCID,Kulikovskaya Irina,Jarocha Danuta,Fraietta Joseph A.,Kim Michele M.,Diffenderfer Eric S.,Cengel Keith A.,Piviani Martina,Radaelli Enrico,Duran-Struuck Raimon,Mason Nicola J.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference87 articles.

1. Exploiting CD1-restricted T cells for clinical benefit;Exley;Mol. Immunol.,2021

2. The burgeoning family of unconventional T cells;Godfrey;Nat. Immunol.,2015

3. The Immunology of CD1- and MR1-Restricted T Cells;Mori;Annu. Rev. Immunol.,2016

4. Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy;Heczey;Blood,2014

5. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting;Rotolo;Cancer Cell,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traversing the bench to bedside journey for iNKT cell therapies;Frontiers in Immunology;2024-08-07

2. Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy;Molecular Therapy;2024-06

3. Human CD4⁺iNKT cell adoptive immunotherapy induces anti‐tumour responses against CD1d‐negative EBV‐driven B lymphoma;Immunology;2024-05-13

4. Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology;Clinical Cancer Research;2024-04-04